Custom service
Custom Membrane Protein Solubilization & Stabilization
Finding the environment that keeps a membrane protein folded — and keeping it.
Solubilisation is where membrane protein projects fail, and it fails quietly: the protein comes out of the membrane, runs cleanly on a gel, and has lost the conformation that made it interesting. A solubilisation screen is therefore an activity screen, not an extraction screen — the condition that extracts the most protein is frequently not the condition that preserves it.
The screen varies three axes simultaneously. Detergent: DDM, LMNG, digitonin, GDN, CHAPS and more, each with a different balance of extraction efficiency and protein stability. Lipid: cholesteryl hemisuccinate, brain polar lipid extract, cardiolipin and target-specific lipids, since many proteins require a specific lipid to hold their fold. Additive: ligands, inhibitors, salt, glycerol and reducing agents that stabilise a particular state.
Stability is measured at every condition by CPM dye or nanoDSF, tracking the unfolding transition of the extracted protein, and by SEC for monodispersity. Where a functional readout exists it is included, because a protein can be thermally stable and functionally dead. The output is a ranked condition table and, where the best condition differs from the one the project started with, a reformatted purification protocol.
The screen is used when a membrane protein extracts but does not survive it, when activity is lost between extraction and assay, and when a published protocol must be adapted to a new construct or host.
It cannot rescue a protein that is intrinsically unstable outside its native membrane, and it is unnecessary when a validated condition already exists for the target in the same construct and host.
Every condition in the matrix is reported with extraction efficiency, thermal transition temperature, SEC profile and, where measured, functional signal. The recommended protocol is verified on a second membrane preparation before delivery.
Service Highlights
- Three-axis screen. Detergent, lipid and additive varied in combination, not one at a time, because the interactions between them decide the outcome.
- Activity-weighted ranking. Conditions ranked by thermal stability and monodispersity, with functional readout where it exists.
- State-locking ligands. Agonists, antagonists and inhibitors added where the target must be held in a defined conformational state.
- Exchange paths. Detergent-to-nanodisc and detergent-to-amphipol exchange protocols included in the deliverable.
- CMY/CPM and nanoDSF. Two orthogonal stability readouts, since some proteins unfold without a clean dye signal.
- Reformulated protocol. The winning condition written into a purification protocol ready for scale-up.
How the work runs
Starting material assessment
Existing expression material characterised — extractability, current stability, available functional assays — or material produced for the screen.
Screen design
Condition matrix designed around the target class and any published precedents, with the readouts defined.
Extraction screen
Conditions run in parallel; extraction efficiency measured by tag signal and SDS-PAGE.
Stability measurement
Extracted protein from each condition measured by CPM or nanoDSF, and by SEC for monodispersity.
Functional confirmation
Ligand binding or activity measured on the top conditions, since thermal stability alone is not proof.
Protocol output
Ranked condition table plus a reformatted extraction and purification protocol.
Specifications & timeline
- Detergents
- DDM, LMNG, digitonin, GDN, DM, CHAPS and others on evaluation
- Lipids
- CHS, cholesteryl myristate, cardiolipin, PIP2, polar lipid extracts
- Readouts
- CPM assay, nanoDSF, SEC-MALS, ligand binding, activity assay
- Input
- Membrane prep from 0.1–5 L culture
- Timeline
- 3–6 weeks per screen
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.